Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Analytical Biochemistry|February 15, 1993
Enzymatic synthesis of 6R-[U-14C]tetrahydrobiopterin from [U-14C]GTPK Hatakeyama, M Hoshiga, S Suzuki, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in miceM Hoshiga, K Hatakeyama, M Watanabe, et al.Circulation Research|December 1, 1995
Alpha-v beta-3 integrin expression in normal and atherosclerotic arteryM Hoshiga, C E Alpers, L L Smith, et al.Gene Therapy|March 15, 2002
Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in ratsH Yasumoto, S Kim, Y Zhan, et al.Cardiovascular Research|December 12, 2001
Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27(Kip1)M Ii, M Hoshiga, R Fukui, et al.Circulation Research|June 9, 2001
Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat arteryY Izumi, S Kim, M Namba, et al.Atherosclerosis|July 11, 1997
Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)R Fukui, N Shibata, E Kohbayashi, et al.Journal of Cardiology|March 14, 2000
Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic studyM Fukai, M Ii, T Nakakoji, et al.Biochemical and Biophysical Research Communications|August 17, 1999
The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cellsN Negoro, M Hoshiga, M Seto, et al.American Journal of Physiology. Cell Physiology|September 26, 2000
Increased migration in late G(1) phase in cultured smooth muscle cellsR Fukui, M Amakawa, M Hoshiga, et al.Pageof 1